Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation.
Hsin-Yeh ChenSheng-Nan LuChao-Hung HungJing-Houng WangChien-Hung ChenYi-Hao YenYuan-Hung KuoKwong-Ming KeePublished in: PloS one (2020)
Our study suggested that presence of end-stage renal disease, m-ALBI grades 2 and 3, APRI >1 and time to 2nd HCC recurrence were all associated with overall survival while the 2nd HCC recurrence was associated with male gender, age ≥65 years, α-fetoprotein level >20 ng/mL, non-surgical therapy, time to IDR, and tumor number> 1.